Table 6 Top 20 novel genes exhibiting genome-wide significance for the TyG index, a marker of insulin resistance, identified within the Taiwan Biobank cohort
CHR | Rank | Gene | Top SNP | Top P | Interval (b38) | GWAS catalog | |
---|---|---|---|---|---|---|---|
2 | 4 | SPATA31H1 | rs1919127 | 6.90E-114 | 27,576,521 | 27,582,722 | NA |
2 | 3 | ZNF512 | rs12989678 | 1.30E-115 | 27,582,968 | 27,623,215 | T2D, TG |
2 | 13 | GPN1 | rs34502053 | 7.90E-68 | 27,628,647 | 27,650,846 | TG, FG, BMI |
2 | 17 | SUPT7L | rs4666010 | 9.90E-45 | 27,650,809 | 27,663,840 | NA |
2 | 15 | SLC4A1AP | rs13021208 | 1.60E−57 | 27,663,470 | 27,694,980 | AD, TG |
2 | 19 | RBKS | rs898034 | 1.50E-38 | 27,781,379 | 27,890,387 | TG |
2 | 20 | MRPL33 | rs3792252 | 2.20E-37 | 27,771,719 | 27,779,733 | TG, FG |
7 | 12 | FZD9 | rs1178947 | 5.80E-69 | 73,433,778 | 73,436,120 | TG, HDL-C |
7 | 11 | BAZ1B | rs111837003 | 1.20E-71 | 73,440,406 | 73,522,293 | TG, HDL-C |
7 | 9 | BCL7B | rs7793710 | 1.10E-83 | 73,536,352 | 73,557,735 | HDL-C |
7 | 8 | TBL2 | rs13246490 | 2.60E-84 | 73,568,945 | 73,578,683 | TG, HDL-C, BMI |
11 | 1 | BUD13 | rs6589565 | 7.3E-445 | 116,748,173 | 116,772,987 | TG, HDL-C |
11 | 2 | APOC3 | rs5128 | 2.80E-152 | 116,829,907 | 116,833,071 | TG, HDL-C |
11 | 18 | APOA1 | rs12718464 | 3.10E-39 | 116,835,752 | 116,837,622 | TG, HDL-C, BMI |
11 | 10 | PAFAH1B2 | rs7925256 | 8.00E-75 | 117,144,283 | 117,178,173 | TG, HDL-C, BMI |
11 | 14 | SIDT2 | rs6589603 | 1.10E−59 | 117,178,743 | 117,197,442 | TG, HDL-C |
11 | 16 | TAGLN | rs588534 | 3.40E−51 | 117,199,294 | 117,207,465 | TG, HDL-C |
19 | 6 | NECTIN2 | rs283811 | 1.60E-94 | 44,846,135 | 44,889,228 | AD, T2D, TG, HDL-C, BMI |
19 | 7 | TOMM40 | rs157582 | 7.50E-94 | 44,891,219 | 44,903,689 | AD, TG, HDL-C, BMI |
19 | 5 | APOE | rs440446 | 1.70E-106 | 44,905,796 | 44,909,393 | AD, T2D, TG, HDL-C, BMI |